Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
Hikida
M
M
Biological Research Laboratories, Lederle (Japan), Ltd., Saitama, Japan.
Yamazaki
Y
Y
Yoshida
M
M
Kawashima
K
K
Nishiki
K
K
Mitsuhashi
S
S
D000818:Animals; D002442:Ceftazidime / Q000494:pharmacology* / Q000627:therapeutic use; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D015378:Imipenem / Q000494:pharmacology / Q000627:therapeutic use; D000077731:Meropenem; D051379:Mice; D008813:Mice, Inbred ICR; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D013845:Thienamycins / Q000494:pharmacology* / Q000627:therapeutic use
D002511:Cephalosporins; D013845:Thienamycins; D015378:Imipenem; D002442:Ceftazidime; D000077731:Meropenem; C065257:biapenem